Dhampur Bio Organics Ltd · NSE:DBOL

Dhampur Bio Organics — Q3 FY2025 Earnings Presentation

35 slides from Dhampur Bio Organics's earnings presentation, Feb 5, 2025

  1. Slide 1: Investor Presentation Q3 FY 2024-25 cover letter

    Dhampur Bio Organics Ltd. Date: February 5, 2025 To, The Manager – Listing The Manager – Listing Dept of Corp. Services, National Stock Exchange of India Ltd. BSE Limited Exchange plaza, Bandra Kurla Complex P.J. Towers, Dalal Street, Fort, Bandra East Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 5

  2. Slide 2: Dhampur Bio Organics Limited Q3 & 9MFY25 Results Presentation

    Dhampur Bio Organics Limited A leading integrated sugarcane processing company in India Q3 & 9MFY25 Results Presentation 1

  3. Slide 3: Safe Harbour Statement

    Safe Harbour Statement This presentation is strictly confidential and may not be copied, published, distributed or transmitted. The information in this presentation is being provided by Dhampur Bio Organics Limited (also referred to as the ‘Company’). By attending the meeting where this presentation

  4. Slide 4: Company Overview

    oo e ee e© e e eo 0 © © © eo oe 0 © © © oe eo © © © © ew Company Overview 2 Oar 8) ge kek a7 hye Ot Bi lfex oe YL. ve oX 4e_ De ‘Kem oe

  5. Slide 5: Company at a Glance

    Company at a Glance Business Overview ₹ 2,361 Crores FY24 Revenue Dhampur Bio Organics Limited (DBO) is a leading cane processing company with experience and pedigree extending across 9 decades. Utilising its advanced and integrated manufacturing setups, DBO capitalises on the favourable trends in t

  6. Slide 6: Our Capacities

    Our Capacities Uttar Asmoli Plant Mansurpur Plant Meerganj Plant Pradesh Capacity Total Capacity (District Sambhal) (District Muzaffanagar) (District Bareilly) Sugar Sugarcane Crushing (TCD) 12,500 8,000 9,000 29,500 Sugar Refinery (TPD) 1,100 900 _ 2,000 Pharma Grade Sugar (TPD)** 700 _ _ 700 LQW S

  7. Slide 7: Key Strengths

    Key Strengths 9+ Deep Focus on Cane Decades of Development Activities to Experience and Pedigree improve recoveries Diversified Business Strong Model Leadership Team and applications Forward Integrated Manufacturing Facilities – 3 Strong Credit Profile – Plants located in Asmoli, Mansurpur & Meergan

  8. Slide 8: Integrated Business Model with diversified Revenue streams

    Integrated Business Model with diversified Revenue streams The company’s Sugar division is fully forward integrated into cogeneration and distillery operations that de-risk the core sugar business of the company Revenue Contribution EBIT Contribution FY22 FY23 FY24 FY22 FY23 FY24 41% 52% 45% 37% 32%

  9. Slide 9: Regular Cane Development & Management activities leading to improved Recovery

    Regular Cane Development & Management activities leading to improved Recovery The company treats land as a long-term principal asset in the sugar business and recognizes the priority of being able to generate more from less DBO’s Cane Development Programme Research Use of Technology Initiatives & Ef

  10. Slide 10: Focussing on Sugar Premiumization

    Focussing on Sugar Premiumization The company intends to enhance production of niche, processed and value-added sugar; and moderate exposure to conventional sugar exposed to commodity price risks Increasing Sugar Realizations (₹/Ton) Packaged sugar, which currently accounts for less than 2% of count

  11. Slide 11: Strong Leadership Team

    Strong Leadership Team Vijay Kumar Goel, Ashwani Kumar Gupta, Gautam Goel, Chairman Vice Chairman Managing Director & CEO The promoter of the undivided company CA with over 40 years of experience in The promoter of the undivided company and on the Board since 1960. Has been the finance, treasury man

  12. Slide 12: Financial & Operational Highlights | Q3 & 9M FY25

    Financial & Operational Highlights | Q3 & 9M FY25 (Standalone Financials) 11

  13. Slide 13: Q3FY25 Highlights

    Q3FY25 | Highlights Sugar Revenue ₹ 740.50 Crores 99.12% Increase / Decrease Revenue Increase / Decrease 74.33% YoY EBITDA Bio-Fuels & Spirits ₹ 16.85 Crores Financial Segmental (17.35)% Margin (Q3FY25) (Q3FY25) Revenue Increase / Decrease 2.28% YoY PAT Country Liquor ₹ (6.21) Crores 74.91% Margin R

  14. Slide 14: 9MFY25 Highlights

    9MFY25 | Highlights Sugar Revenue ₹ 2,011.92 Crores 13.27% Increase / Decrease Revenue Increase / Decrease 13.89% YoY EBITDA Bio-Fuels & Spirits ₹ 44.10 Crores Financial Segmental (46.48)% Margin (9MFY25) (9MFY25) Revenue Increase / Decrease 2.19% YoY PAT Country Liquor ₹ (27.56) Crores 47.71% Margi

  15. Slide 15: Net Revenue Analysis (Q3FY25 vs Q3FY24)

    Net Revenue Analysis (Q3FY25 vs Q3FY24) (₹ In Crores) ₹ 234 ₹ 486 ₹ 12 - ₹ 13 ₹296 - ₹ 21 -₹8 - ₹ 14 Revenue Sugar Sugar Ethanol Country Bagasse Others* Revenue Q3FY24* Quantity Realisation Liquor Quantity* Quantity Q3FY25* 14 * Revenue net of excise; Others includes other ancillary products

  16. Slide 16: Key Financials – Q3 & 9M FY25

    Key Financials – Q3 & 9M FY25 (₹ In Crores) Revenue from Operations EBITDA & EBITDA Margin (%) PAT & PAT Margin (%) 3.03% 2.28% 4.22% 2.19% -0.98% -0.84% 0.43% -1.37% 7.60 10.00 74.54 80.00 2,011.92 5.00 1,766.54 70.00 - -6.21 60.00 (5.00) 44.10 -4.16 50.00 (10.00) 40.00 740.50 (15.00) 30.00 424.78

  17. Slide 17: Profit & Loss Statement – Q3 & 9MFY25

    Profit & Loss Statement – Q3 & 9MFY25 (₹ In Crores) Particulars Q3FY25 Q3FY24 YoY 9MFY25 9MFY24 YoY Revenue from Operations 740.50 424.78 74.33% 2,011.92 1,766.54 13.89% • Revenue at ₹ 740.5 Crores (Including excise duty) in Q3 FY25 – EBITDA 16.85 12.89 30.72% 44.10 74.54 (40.84%) – Sugar sales up b

  18. Slide 18: Segmental Performance | Q3FY25

    Segmental Performance | Q3FY25 (Standalone Financials) 17

  19. Slide 19: Segment Highlights – Q3 & 9MFY25

    Segment Highlights – Q3 & 9MFY25 Revenue (₹ In Crores) & EBIT Margin (%) Sugar Biofuels & Spirits Country Liquor -3.86% 3.11% 1.02% 2.00% 6.53% -0.96% 9.50% 3.15% 1.77% 1.68% 1.63% 1.50% 1,305.04 1,400.00 900.00 900.00 1,200.00 1,152.18 800.00 800.00 700.00 700.00 659.80 1,000.00 600.00 600.00 800.0

  20. Slide 20: Segment Overview – Q3 & 9MFY25

    Segment Overview – Q3 & 9MFY25 (₹ In Crores) Segment Performance Particulars (₹ in Crores) Q3FY25 Q3FY24 YoY 9MFY25 9MFY24 YoY Sugar Revenue 473.51 237.80 99.12% 1,305.04 1,152.18 13.27% EBIT 14.72 (9.17) NM 26.11 11.72 122.78% EBIT Margin (%) 3.11% (3.86%) NM 2.00% 1.02% 98 bps Biofuels & Spirits R

  21. Slide 21: Operational Performance – Q3 & 9MFY25

    Operational Performance – Q3 & 9MFY25 Particulars UOM Q3FY25 Q3FY24 9MFY25 9MFY24 Sugar Sugar Production Tons 1,01,401 1,37,761 1,28,212 1,87,676 Sugar Sales Tons 89,252 30,948 2,83,556 2,23,785 Avg. Realisation ₹/Ton 38,714 40,142 38,895 37,966 Inventory* Tons 1,11,428 1,06,578 1,11,428 1,06,578 Va

  22. Slide 22: Operational Highlights - Sugar

    Operational Highlights - Sugar Cane Crushed, Sugar Production & Recovery Sugar Sales & Realisation Cane Crushed (Lac Tons) Sugar Production (Lac Tons) Net Sugar Recovery (%) Sugar Sales (Lac Tons) Avg. Realisation (₹/Ton) 25.00 5.00 45,000 19.99 14.00% 4.50 9.51% 9.54% 40,142 37,966 15.82 9.41% 38,8

  23. Slide 23: Operational Highlights - Power

    Operational Highlights - Power Power Generation (Mn Units) Exports (Mn Units) Average Realisation (₹/Unit) 182.87 200.00 4.00 3.44 3.44 3.44 3.44 180.00 3.50 160.00 3.00 140.00 2.50 99.73 105.69 120.00 100.00 87.58 2.00 80.00 1.50 60.00 58.24 37.48 35.71 1.00 29.16 40.00 0.50 20.00 - - Q3FY24 Q3FY25

  24. Slide 24: Operational Highlights - Bio Fuels & Spirits

    Operational Highlights - Bio Fuels & Spirits Ethanol Production, Sales & Realisation C-Heavy Derived Ethanol Ethanol Production (Mn BL) Ethanol Sales (Mn BL) Average Realisation (₹/BL) Production (Mn BL) Sales (Mn BL) Avg. Realisation (₹/BL) 64.02 58.52 58.87 70.94 59.92 67.66 80.00 70.00 70.00 60.0

  25. Slide 25: Operational Highlights - Country Liquor

    Operational Highlights - Country Liquor Country Liquor Sales (Cases) Avg. Realisation (₹/Case) 30,00,000 500.00 26,86,104 450.00 25,00,000 400.00 18,76,830 350.00 20,00,000 280.15 274.67 274.54 300.00 15,00,000 282.27 250.00 11,50,923 200.00 10,00,000 6,86,794 150.00 100.00 5,00,000 50.00 - - Q3FY24

  26. Slide 26: Balance Sheet Highlights

    Balance Sheet Highlights (₹ In Crores) Long Term Loans Working Capital Loan Long Term Debt : Equity Ratio ₹233 Crores ₹380 Crores 0.24 times as on December 31, 2024 as on December 31, 2024 as on December 31, 2024 ₹239 Crores ₹322 Crores 0.24 times as on September 30, 2024 as on September 30, 2024 as

  27. Slide 27: Industry dynamics

    oo e e e© e 8 @ oe © © © © ew eo © © © © © eo 0 © © © oe Industry dynamics iat mag ee eae eee © ee 0 6: 0 erepte. 6) « me

  28. Slide 28: Sugar Industry Outlook

    Sugar Industry Outlook... • The gross sugar production for SS 2024-25 has been revised to 31 million tons. Sugar diversion towards ethanol is expected to be around 3.75 million tons. Domestic sugar consumption is projected at 28 million tons. • The government has allowed the export of 1 million tons

  29. Slide 29: Balanced Growth for a Sustainable Tomorrow

    Balanced Growth for a Sustainable Tomorrow Summary of ESG content 28

  30. Slide 30: Our ESG Strategy Construct

    Our ESG Strategy Construct During FY 2022-23, the Company conducted a materiality assessment to identify sustainability issues that are important to both the company and its stakeholders. This assessment involved identifying potential issues, engaging with stakeholders to understand their perspectiv

  31. Slide 31: Our Contribution to UN SDGs

    Our Contribution to UN SDGs Our material topics align with the following Sustainable Development Goals set forth by United Nations (UN SDGs) Responsible Governance People First Organisational ethics, values and Diversity and Inclusion governance Training and Development IT and Cybersecurity Health,

  32. Slide 32: Annexures

    eo e e © e 8 © oe © © © © ew oe © © © © oe eo 8 © © © ew Annexures Pat had ee ae er © —eeereiine Se: .0 Gen e 6 « ee

  33. Slide 33: Our Certifications

    Our Certifications Certificate of Drug Formulation Approval Certificate of Drug Formulation Approval Dhampur Bio Organics Limited, Unit-Asmoli Division Sugar has been Dhampur Bio Organics Limited, Unit-Mansurpur has been certified with granted license(s) to manufacture Pharmaceutical Grade Sugar Qua

  34. Slide 34: Shareholders Information

    Shareholders Information Individual Shareholder Information Shareholders as on 31st December 2024 40.14% BSE Ticker 543593 Others NSE Symbol DBOL 7.49% Market Cap (in Rs. Crores) 754.83 NRI % Free- float 49.22% 0.93% FII Free Float Market Cap (in Rs. Crores) 522.98 0.66% Shares Outstanding (Crores)

  35. Slide 35: Thank You

    Thank You Ernst & Young LLP: Dhampur Bio Organics Limited: Rohit Anand: Rohit.anand4@in.ey.com Nalin Kumar Gupta, Chief Financial Officer Riddhant Kapur: Riddhant.kapur@in.ey.com nalingupta@dhampur.com Anubhav Khandelwal: Anubhav.khandelwal@.in.ey.com Corp. Office: Second Floor, Plot No. 201, Okhla

Dhampur Bio Organics — Q3 FY2025 Earnings Presentation on 6ix